<VariationArchive RecordType="classified" VariationID="2505468" VariationName="NM_138288.4(SPTSSA):c.171_172del (p.Gln58fs)" VariationType="Deletion" Accession="VCV002505468" Version="2" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-12-17" DateCreated="2023-06-17" MostRecentSubmission="2023-12-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2670432" VariationID="2505468">
      <GeneList>
        <Gene Symbol="SPTSSA" FullName="serine palmitoyltransferase small subunit A" GeneID="171546" HGNC_ID="HGNC:20361" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>14q13.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="14" Accession="NC_000014.9" start="34432788" stop="34462240" display_start="34432788" display_stop="34462240" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="14" Accession="NC_000014.8" start="34902143" stop="34931467" display_start="34902143" display_stop="34931467" Strand="-" />
          </Location>
          <OMIM>613540</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_138288.4(SPTSSA):c.171_172del (p.Gln58fs)</Name>
      <CanonicalSPDI>NC_000014.9:34435244:GGGG:GG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>14q13.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="14" Accession="NC_000014.9" start="34435245" stop="34435246" display_start="34435245" display_stop="34435246" variantLength="2" positionVCF="34435244" referenceAlleleVCF="TGG" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="14" Accession="NC_000014.8" start="34904451" stop="34904452" display_start="34904451" display_stop="34904452" variantLength="2" positionVCF="34904450" referenceAlleleVCF="TGG" alternateAlleleVCF="T" />
      </Location>
      <OtherNameList>
        <Name>2-BP DEL, NT171</Name>
      </OtherNameList>
      <ProteinChange>Q58fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_138288.3" sequenceAccession="NM_138288" sequenceVersion="3" change="c.171_172del">
            <Expression>NM_138288.3:c.171_172del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000014.8" sequenceAccession="NC_000014" sequenceVersion="8" change="g.34904453_34904454del" Assembly="GRCh37">
            <Expression>NC_000014.8:g.34904453_34904454del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000014.9" sequenceAccession="NC_000014" sequenceVersion="9" change="g.34435247_34435248del" Assembly="GRCh38">
            <Expression>NC_000014.9:g.34435247_34435248del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_138288.4" sequenceAccession="NM_138288" sequenceVersion="4" change="c.171_172del" MANESelect="true">
            <Expression>NM_138288.4:c.171_172del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_612145.2" sequenceAccession="NP_612145" sequenceVersion="2" change="p.Gln58fs">
            <Expression>NP_612145.2:p.Gln58fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="613540.0002" DB="OMIM" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_138288.4(SPTSSA):c.171_172del (p.Gln58fs) AND Spastic paraplegia 90B, autosomal recessive" Accession="RCV003234735" Version="2">
        <ClassifiedConditionList TraitSetID="85365">
          <ClassifiedCondition DB="MedGen" ID="C5830578">Spastic paraplegia 90B, autosomal recessive</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2023-12-07" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-12-07" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-06-17" MostRecentSubmission="2023-12-17">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">36718090</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="85365" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="68046" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Spastic paraplegia 90B, autosomal recessive</ElementValue>
                <XRef ID="MONDO:0957309" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">SPG90B</ElementValue>
                <XRef Type="MIM" ID="620417" DB="OMIM" />
              </Symbol>
              <XRef ID="C5830578" DB="MedGen" />
              <XRef ID="MONDO:0957309" DB="MONDO" />
              <XRef Type="MIM" ID="620417" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7351989" SubmissionDate="2023-06-14" DateLastUpdated="2023-12-17" DateCreated="2023-06-17">
        <ClinVarSubmissionID localKey="613540.0002_SPASTIC PARAPLEGIA 90B, AUTOSOMAL RECESSIVE (1 patient)" title="SPTSSA, 2-BP DEL, NT171_SPASTIC PARAPLEGIA 90B, AUTOSOMAL RECESSIVE (1 patient)" />
        <ClinVarAccession Accession="SCV003932618" DateUpdated="2023-12-17" DateCreated="2023-06-17" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-07">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a 22-year-old man (patient 3), born to nonconsanguineous Ashkenazi-Jewish parents, with autosomal recessive spastic paraplegia-90B (SPG90B; 620417), Srivastava et al. (2023) identified homozygosity for a 2-bp deletion (c.171_172del, NM_138288.3) in the SPTSSA gene, resulting in a frameshift and premature termination (Gln58AlafsTer10). The mutation, which was identified by whole-exome sequencing, was predicted to result in substitution of the C-terminal 14 amino acids with 10 out-of-frame amino acids. The variant was present in the gnomAD database in the general population at an allele frequency of 0.0000517 and in the Ashkenazi Jewish population at an allele frequency of 0.001191, with no homozygotes reported. Expression of SPTSSA with the c.171_172del mutation in HEK293 cells led to higher intracellular serine palmitoyltransferase activity and de novo sphingolipid synthesis compared to cells expressing wildtype SPTSSA. Furthermore, sphingolipid synthesis was less responsive to cotransfection with ORMDL3 in the cells expressing the mutant SPTSSA compared to wildtype.</Attribute>
              <Citation>
                <CitationText>Srivastava, S., Shaked, H. M., Gable, K., Gupta, S. D., Pan, X., Somashekarappa, N., Han, G., Mohassel, P., Gotkine, M., Doney, E., Goldenberg, P., Tan, Q. K. G., and 15 others SPTSSA variants alter sphingolipid synthesis and cause a complex hereditary spastic paraplegia. Brain 146: 1420-1435, 2023.</CitationText>
              </Citation>
              <XRef DB="OMIM" ID="620417" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SPTSSA" />
          </GeneList>
          <Name>SPTSSA, 2-BP DEL, NT171</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">2-BP DEL, NT171</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="613540.0002" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">SPASTIC PARAPLEGIA 90B, AUTOSOMAL RECESSIVE (1 patient)</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
  </ClassifiedRecord>
</VariationArchive>

